# OnCo record nct06122584 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct06122584/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct06122584", "NCT06122584" ;
  schema:name "Diagnostic Performance of [18F]PSMA-1007 PET/CT Imaging in Patients With Newly-Diagnosed Prostate Cancer"@en ;
  schema:description "A phase 3 trial of PSMA-1007 F-18 run by ABX advanced biochemical compounds GmbH in prostate cancer, now recruiting."@en ;
  schema:url <https://onco.cc/trials/nct06122584/> ;
  schema:dateModified "2026-09-16"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT06122584> ;
  onco:status "recruiting" ;
  onco:tag "ctgov-ingest" ;
  onco:phase "3" ;
  schema:startDate "2024-06-13" ;
  onco:cancers <https://onco.cc/cancers/prostate/>, <https://onco.cc/cancers/prostate-high-risk/> ;
  onco:drugs <https://onco.cc/drugs/psma-1007-f18/> ;
  onco:companies <https://onco.cc/companies/abx-advanced-biochemical-compounds/> .
